Brigit Biofarmaka Teknologi Tbk. vs Total Bangun Persada Tbk. — how do they compare? Brigit Biofarmaka Teknologi Tbk. trades at Rp254 (market cap 172.82B, 592.2K 24h volume), while Total Bangun Persada Tbk. trades at Rp1,055 (market cap 3.56T, 919.7K 24h volume). The key difference: Total Bangun Persada Tbk. is far larger — about 20.6× Brigit Biofarmaka Teknologi Tbk.'s market cap, and Total Bangun Persada Tbk. is more actively traded (919.7K versus 592.2K). Which is the better fit depends on your goals.
| OBAT | TOTL | |
|---|---|---|
Market Cap | 172.82B | 3.56T |
Volume | 592.2K | 919.7K |
Lot | 5.92K | 9.2K |
Turnover | 147.05M | 966.06M |
Average Price | 248.31 | 1,050.41 |
Value | 147.05M | 966.06M |
Indicative Equilibrium Price | 254 | 1,055 |
Indicative Equilibrium Volume | 10 | 294 |
Trailing returns across standard periods
Latest headlines on both assets
PT. Brigit Biofarmaka Teknologi Tbk. (the Company) was established based on Notarial Deed No. 103 dated December 14, 2015 of Yoerista Arya Megasari, S.H., M.Kn., Notary in Sukoharjo. The company starts production commercially in 2018.
Read more on OBAT →PT Total Bangun Persada (the company) was established under its original name of PT Tjahja Rimba Kentjana on Sep 4, 1970 then changed to PT Total Bangun Persada based on Notaries Deed dated Jul 24, 1981 and the deed of establishment was approved by the the Ministry of Justice dated Nov 4, 1981. The Company’s articles of association has been amended several times, most recently by notarial deed No. 47 of Haryanto, S.H., dated Oct 24, 2005, concerning the amendment of Company's authorized and paid up capital, and public offering.
Read more on TOTL →